Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""BMC cancer [BMC Cancer] NLMUID: 100967800"" wg kryterium: JN


Tytuł :
Prognostic value of preoperative peripheral blood mean platelet volume/platelet count ratio (MPV/PC) in patients with resectable cervical cancer.
Autorzy :
Deng Q; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Street, Suzhou, 215004, Jiangsu Province, China.
Long Q; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Street, Suzhou, 215004, Jiangsu Province, China.
Liu Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Street, Suzhou, 215004, Jiangsu Province, China.
Yang Z; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Street, Suzhou, 215004, Jiangsu Province, China.
Du Y; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Street, Suzhou, 215004, Jiangsu Province, China.
Chen X; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Street, Suzhou, 215004, Jiangsu Province, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 29; Vol. 21 (1), pp. 1282. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer.
Autorzy :
Byeon S; Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, South Korea.
Kim H; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea.
Jeon HG; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Seo SI; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Jeon SS; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee HM; Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee SI; Internal Medicine, Dankook University College of Medicine, Cheonan, Chungcheongnam-do, Korea.
Park SH; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 29; Vol. 21 (1), pp. 1281. Date of Electronic Publication: 2021 Nov 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Temporality of clinical factors associated with pancreatic cancer: a case-control study using linked electronic health records.
Autorzy :
Dayem Ullah AZM; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK. .; Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK. .
Stasinos K; Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK.; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
Chelala C; Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK.; Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Kocher HM; Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK.; Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 27; Vol. 21 (1), pp. 1279. Date of Electronic Publication: 2021 Nov 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The risk of lymph node metastasis in gastric cancer conforming to indications of endoscopic resection and pylorus-preserving gastrectomy: a single-center retrospective study.
Autorzy :
Yanzhang W; Department of Gastrointestinal Surgery, First Affiliated Hospital of Sun Yat-sen University, Zhongshan 2nd street, No. 58, Guangzhou, 510080, Guangdong, China.
Guanghua L; Department of Gastrointestinal Surgery, First Affiliated Hospital of Sun Yat-sen University, Zhongshan 2nd street, No. 58, Guangzhou, 510080, Guangdong, China.
Zhihao Z; Department of Gastrointestinal Surgery, First Affiliated Hospital of Sun Yat-sen University, Zhongshan 2nd street, No. 58, Guangzhou, 510080, Guangdong, China.
Zhixiong W; Department of Gastrointestinal Surgery, First Affiliated Hospital of Sun Yat-sen University, Zhongshan 2nd street, No. 58, Guangzhou, 510080, Guangdong, China. .
Zhao W; Department of Gastrointestinal Surgery, First Affiliated Hospital of Sun Yat-sen University, Zhongshan 2nd street, No. 58, Guangzhou, 510080, Guangdong, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 27; Vol. 21 (1), pp. 1280. Date of Electronic Publication: 2021 Nov 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer.
Autorzy :
Sunde B; Division of Surgery, Department of Clinical Science Intervention and Technology, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, SE-14186, Stockholm, Sweden. .
Lindblad M; Division of Surgery, Department of Clinical Science Intervention and Technology, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, SE-14186, Stockholm, Sweden.
Malmström M; Lund University, Department of Health Sciences and Department of surgery, Skane University Hospital, 221 85, Lund, Sweden.
Hedberg J; Department of Surgical Sciences, Uppsala University, 751 85, Uppsala, Sweden.
Lagergren P; Surgical Care Science, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden.; Department of Surgery and Cancer, Imperial College London, London, SW7 2AZ, UK.
Nilsson M; Division of Surgery, Department of Clinical Science Intervention and Technology, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, SE-14186, Stockholm, Sweden.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 26; Vol. 21 (1), pp. 1277. Date of Electronic Publication: 2021 Nov 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials.
Autorzy :
Ma HC; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Liu YH; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
Ding KL; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Liu YF; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Zhao WJ; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Zhu YJ; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.; Guangdong Provincial Key Laboratory, of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, 510120, China.
Chang XS; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Chen YD; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
Xiao ZZ; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
Yu YY; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
Zhou R; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Zhang HB; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China. .; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. .; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. .; Guangdong Provincial Key Laboratory, of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, 510120, China. .; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 26; Vol. 21 (1), pp. 1278. Date of Electronic Publication: 2021 Nov 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.
Autorzy :
Zong JF; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Liang QD; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Lu QJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Liu YH; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Xu HC; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Chen BJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Guo QJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Xu Y; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Hu CR; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.
Pan JJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.
Lin SJ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, No. 420 Fuma Road, Fuzhou, 350014, Fujian, China. .; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 25; Vol. 21 (1), pp. 1274. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effect of self-regulatory behaviour change techniques and predictors of physical activity maintenance in cancer survivors: a 12-month follow-up of the Phys-Can RCT.
Autorzy :
Mazzoni AS; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden. .
Brooke HL; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Berntsen S; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.; Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway.
Nordin K; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.; Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway.
Demmelmaier I; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.; Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 25; Vol. 21 (1), pp. 1272. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis.
Autorzy :
Ngamphaiboon N; Medical Oncology Unit, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Ithimakin S; Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Siripoon T; Medical Oncology Unit, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Sintawichai N; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University & The King Chulalongkorn Memorial Hospital, 1873 Rama IV Rd., Pathumwan, Bangkok, 10330, Thailand.
Sriuranpong V; Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University & The King Chulalongkorn Memorial Hospital, 1873 Rama IV Rd., Pathumwan, Bangkok, 10330, Thailand. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 25; Vol. 21 (1), pp. 1275. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts.
Autorzy :
Wang C; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Jiang X; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Huang B; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Zhou W; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Cui X; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Zheng C; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Liu F; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Bi J; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Zhang Y; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Luo H; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Yuan L; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Yang J; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China.
Yu Y; Department of Hepatopancreatobiliary Surgery, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China. .; Center for Diagnosis and Treatment of Digestive Diseases, the Second People' s Hospital of Yibin, Yibin, Sichuan, 644000, P.R. China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 25; Vol. 21 (1), pp. 1276. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Community oncologists' perceptions and utilization of large-panel genomic tumor testing.
Autorzy :
Anderson EC; Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, USA. .; Tufts University School of Medicine, Boston, MA, USA. .
Hinton AC; Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, USA.
Lary CW; Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, USA.; Tufts University School of Medicine, Boston, MA, USA.
Fenton ATHR; Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, USA.
Antov A; The Jackson Laboratory, Augusta, ME, USA.
Edelman E; The Jackson Laboratory, Augusta, ME, USA.
Helbig P; The Jackson Laboratory, Augusta, ME, USA.
Reed K; The Jackson Laboratory, Augusta, ME, USA.
Miesfeldt S; Maine Medical Center, Portland, ME, USA.
Thomas CA; New England Cancer Specialists, Scarborough, ME, USA.
Hall MJ; Fox Chase, Philadelphia, PA, USA.
Roberts JS; University of Michigan School of Public Health, Ann Arbor, MI, USA.
Rueter J; The Jackson Laboratory, Augusta, ME, USA.
Han PKJ; Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, ME, USA.; Tufts University School of Medicine, Boston, MA, USA.
Pokaż więcej
Corporate Authors :
MCGI Working Group
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 25; Vol. 21 (1), pp. 1273. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The effect of hypoxia on PD-L1 expression in bladder cancer.
Autorzy :
Smith V; Division of Cancer Sciences, University of Manchester, M20 4BX, Manchester, UK. .
Mukherjee D; Division of Cancer Sciences, University of Manchester, M20 4BX, Manchester, UK.
Lunj S; Division of Cancer Sciences, University of Manchester, M20 4BX, Manchester, UK.
Choudhury A; Division of Cancer Sciences, University of Manchester, M20 4BX, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.; Manchester Academic Health Science Centre, Manchester, UK.
Hoskin P; Division of Cancer Sciences, University of Manchester, M20 4BX, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.; Manchester Academic Health Science Centre, Manchester, UK.
West C; Division of Cancer Sciences, University of Manchester, M20 4BX, Manchester, UK.
Illidge T; Division of Cancer Sciences, University of Manchester, M20 4BX, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.; Manchester Academic Health Science Centre, Manchester, UK.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 25; Vol. 21 (1), pp. 1271. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Identification of a novel metabolism-related gene signature associated with the survival of bladder cancer.
Autorzy :
Li X; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.; Urological disease clinical medical center of yunnan province, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.; Scientific and Technological Innovation Team of Basic and Clinical Research of Bladder Cancer in Yunnan Universities, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.
Fu S; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.; Urological disease clinical medical center of yunnan province, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.; Scientific and Technological Innovation Team of Basic and Clinical Research of Bladder Cancer in Yunnan Universities, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.
Huang Y; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.; Urological disease clinical medical center of yunnan province, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.; Scientific and Technological Innovation Team of Basic and Clinical Research of Bladder Cancer in Yunnan Universities, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.
Luan T; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.; Urological disease clinical medical center of yunnan province, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.; Scientific and Technological Innovation Team of Basic and Clinical Research of Bladder Cancer in Yunnan Universities, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China.
Wang H; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China. .; Urological disease clinical medical center of yunnan province, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China. .; Scientific and Technological Innovation Team of Basic and Clinical Research of Bladder Cancer in Yunnan Universities, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China. .
Wang J; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China. .; Urological disease clinical medical center of yunnan province, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China. .; Scientific and Technological Innovation Team of Basic and Clinical Research of Bladder Cancer in Yunnan Universities, The Second Affiliated Hospital of Kunming Medical University, No. 347, Dianmian street, Wuhua District, Kunming, 650101, Yunnan, People's Republic of China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 24; Vol. 21 (1), pp. 1267. Date of Electronic Publication: 2021 Nov 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma.
Autorzy :
Tang Y; School of Computer Science and Engineering, University of Electronic Science and Technology of China, No. 4, Section 2, North Jianshe Road, Chengdu, 610054, Sichuan, China.
Yang CM; Department of Radiology, The Affiliated Hospital of Southwest Medical University, and Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, 646000, Sichuan, China.
Su S; Department of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, 25 Taiping Street, Luzhou, 646000, Sichuan, China.
Wang WJ; School of Information and Software Engineering, University of Electronic Science and Technology of China, No. 4, Section 2, North Jianshe Road, Chengdu, 610054, Sichuan, China.
Fan LP; Department of Ultrasound, The Affiliated Hospital of Southwest Medical University, 25 Taiping Street, Luzhou, 646000, Sichuan, China. .
Shu J; Department of Radiology, The Affiliated Hospital of Southwest Medical University, and Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, 646000, Sichuan, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 24; Vol. 21 (1), pp. 1268. Date of Electronic Publication: 2021 Nov 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
MRI-based radiomics and ADC values are related to recurrence of endometrial carcinoma: a preliminary analysis.
Autorzy :
Zhang K; Department of Radiation Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, 230001, China.
Zhang Y; Department of Radiation Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, 230001, China.
Fang X; Department of Radiology, First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, China.
Dong J; Department of Radiation Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, 230001, China. .; Department of Radiology, First Affiliated Hospital of University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, 230031, China. .
Qian L; Department of Radiation Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, 230001, China. .; Department of Radiation Oncology, First Affiliated Hospital of University of Science and Technology of China, Hefei, 230001, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 24; Vol. 21 (1), pp. 1266. Date of Electronic Publication: 2021 Nov 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter.
Autorzy :
Sabazade S; St. Erik Eye Hospital, Eugeniavägen 12, 17164, Stockholm, Sweden.; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden.
Herrspiegel C; St. Erik Eye Hospital, Eugeniavägen 12, 17164, Stockholm, Sweden.; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden.
Gill V; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden.; Department of Pathology, Västmanland Hospital Västerås, Västerås, Sweden.
Stålhammar G; St. Erik Eye Hospital, Eugeniavägen 12, 17164, Stockholm, Sweden. .; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 24; Vol. 21 (1), pp. 1270. Date of Electronic Publication: 2021 Nov 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.
Autorzy :
Masuda N; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan. .; Present address: Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. .
Tamura K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Present address: Department of Medical Oncology, Shimane University Hospital, Izumo, Shimane, Japan.
Yasojima H; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Shimomura A; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Present address: Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Lee MJ; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Yuno A; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Present address: Department of Oral and Maxillofacial Surgery, Kumamoto University Hospital, Kumamoto, Japan.
Trepel J; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Kimura R; R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan.
Nishimura Y; R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan.
Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 24; Vol. 21 (1), pp. 1269. Date of Electronic Publication: 2021 Nov 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Survival-associated N -adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification.
Autorzy :
Qu J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, 250117, China.
Wang L; Department of Oncology, Jiujiang University Affiliated Hospital, Jiujiang, 332000, China.
Jiang M; Cancer Precision Medicine Center, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266003, China.
Wei Z; Pathology Department, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266003, China.
Fu G; Pathology Department, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266003, China.
Zhang X; Cancer Precision Medicine Center, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266003, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 24; Vol. 21 (1), pp. 1265. Date of Electronic Publication: 2021 Nov 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Expectations of treatment outcomes in patients with spinal metastases; what do we tell our patients? A qualitative study.
Autorzy :
Versteeg AL; Division of Imaging and Cancer, University Medical Center Utrecht, University of Utrecht, PO Box 85500, 3508, GA, Utrecht, the Netherlands. .; Division of Imaging and Cancer, Department of Radiotherapy, University Medical Center Utrecht, Universiteitsweg 100, 3584, CG, Utrecht, the Netherlands. .
Gal R; Division of Imaging and Cancer, University Medical Center Utrecht, University of Utrecht, PO Box 85500, 3508, GA, Utrecht, the Netherlands.
Charest-Morin R; Division of Spine, Department of Orthopaedics, University of British Columbia and Vancouver General Hospital, Vancouver, British Columbia, Canada.
Verlaan JJ; Department of Orthopaedic surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Wessels H; Department of Corporate Communications, University Medical Center Utrecht, Utrecht, The Netherlands.
Fisher CG; Division of Spine, Department of Orthopaedics, University of British Columbia and Vancouver General Hospital, Vancouver, British Columbia, Canada.
Verkooijen HM; Division of Imaging and Cancer, University Medical Center Utrecht, University of Utrecht, PO Box 85500, 3508, GA, Utrecht, the Netherlands.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 23; Vol. 21 (1), pp. 1263. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis.
Autorzy :
Xin Y; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China. .
Shen G; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China. .
Zheng Y; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China. .
Guan Y; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Huo X; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Li J; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Ren D; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Zhao F; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Liu Z; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Li Z; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Zhao J; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Nov 23; Vol. 21 (1), pp. 1261. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies